CCRN — Cross Country Healthcare Income Statement
0.000.00%
Last trade - 00:00
- $478.73m
- $409.13m
- $2.02bn
- 91
- 88
- 35
- 82
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 822 | 836 | 1,677 | 2,807 | 2,020 |
Cost of Revenue | |||||
Gross Profit | 204 | 203 | 375 | 628 | 450 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 840 | 846 | 1,537 | 2,537 | 1,909 |
Operating Profit | -17.7 | -9.16 | 139 | 269 | 111 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -24.2 | -12.3 | 133 | 256 | 103 |
Provision for Income Taxes | |||||
Net Income After Taxes | -55.9 | -12.1 | 132 | 188 | 72.6 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -57.7 | -13 | 132 | 188 | 72.6 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -57.7 | -13 | 132 | 188 | 72.6 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -1.18 | 0.044 | 3.68 | 5.25 | 2.17 |